Blood Irradiation Therapy - Skyrizi (Risankizumab-Rzaa) Interaction
Herbal: Blood Irradiation Therapy
Drug: Risankizumab-Rzaa
Brand names:
Skyrizi
Medical Content Editor Dr. Brian Staiger, PharmD
Last updated
Jul 22, 2023
Interaction Details
Risankizumab-Rzaa is classified as belonging to the following category: Immunosuppressants
Clinical research suggests that blood irradiation therapy may stimulate immune function in some patients. Theoretically, concurrent use of blood irradiation therapy might interfere with immunosuppressive therapy.
Immunosuppressant drugs include azathioprine (Imuran), basiliximab (Simulect), cyclosporine (Neoral, Sandimmune), daclizumab (Zenapax), muromonab-CD3 (OKT3, Orthoclone OKT3), mycophenolate (CellCept), tacrolimus (FK506, Prograf), sirolimus (Rapamune), prednisone (Deltasone, Orasone), and other corticosteroids (glucocorticoids).
Interaction Rating
Likelihood of Occurrence
PossibleInteraction has been documented in animal or in lab research, or the interaction has been documented in humans but is limited to case reports or conflicting clinical research exists
References
- Chepik EB, Shamanova MG, Medvedeva EV, et al. Photochemotherapy in the treatment of acute pneumonias]. Vestn Ross Akad Med Nauk 1994;(9):48-51.
- Tkachenko IuIa, Kovalenko NN, Kogosova LS, et al. [The clinico-immunological characteristics of bronchial asthma patients undergoing autologous ultraviolet blood irradiation]. Lik Sprava 1993;(8):59-62.
- Gorskova VA, Evmenov VF, Zaitseva TS, et al. [Effects of surgical intervention and intravascular irradiation of blood with helium-neon laser on the state humoral autoimmunity in oncological patients]. Khirurgiia (Mosk) 1991;(9):92-8.
- Xiao X, Chu X, Ni J. [Effect of intravascular laser irradiation of blood and traditional Chinese medical therapy on immune function in senile cerebral infarction patients of kidney deficiency type]. Zhongguo Zhong Xi Yi Jie He Za Zhi 2000;20(4):264-6.
- Nazarov IP, Popov AA, Mal'tseva MA, et al. [State of neuroendocrine systems and immunity in patients with burns]. Anesteziol Reanimatol 1994;(1):5-8.
- Neimark AI, Muzalevskaia NI. [Low-intensity laser radiation in preoperative preparation of patients with benign prostatic hyperplasia]. Urologiia 2000;(1):11-5.
- Chernushenko EF, Dziublik AI, Naida IV, et al. [Effects of intravascular laser irradiation of blood on the immune status of patients with bronchial obstructive diseases of the lungs]. Klin Med (Mosk) 1991;69(12):51-3.
Risankizumab-Rzaa Overview
-
Risankizumab-rzaa injection is used to treat moderate to severe plaque psoriasis (a skin disease in which red, scaly patches form on some areas of the body) in adults whose psoriasis is too severe to be treated by topical medications alone. It is also used to treat active psoriatic arthritis (condition that causes joint pain and swelling and scales on the skin) in adults. Risankizumab-rzaa injection is also used to treat Crohn's disease (a condition in which the body attacks the lining of the digestive tract, causing pain, diarrhea, weight loss, and fever) in adults. Risankizumab-rzaa is in a class of medications called monoclonal antibodies. It works by stopping the action of certain cells in the body that cause the symptoms of psoriasis.
Blood Irradiation Therapy - More Interactions
Blood Irradiation Therapy interacts with 311 drugs
Interaction Rating Key
These severity listings are for informational use only. Never start, stop or otherwise change your therapy before speaking with your provider.
Major | The combined use of these agents is strongly discouraged as serious side effects or other negative outcomes could occur. |
Moderate | Use cautiously under the care of a healthcare professional or avoid this combination. A significant interaction or negative outcome could occur. |
Minor | Be aware that there is a chance of an interaction. Watch for warning signs of a potential interaction. |
Unknown | No interactions have been reported or no interaction data is currently available. |
Return to the main herbal interaction checker page
Parts of this content are provided by the Therapeutic Research Center, LLC.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC
Drug descriptions are provided by MedlinePlus.